Wachtell and Cravath lead for Pfizer/Mylan merger
Pfizer and Mylan have tapped Wachtell Lipton Rosen & Katz and Cravath Swaine & Moore, respectively, to oversee the proposed combination of Pfizer’s Upjohn and generic drugmaker Mylan.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10